- (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]
Adverse reactions attributed to entire drug class 'Angiogenesis inhibitor / antiangiogenic agent'
Please login to view adverse reactions.
- (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]
- (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]
Lymphopenia (lymphocytopenia) / lymphocytes decreased
- (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]
Adverse effects / adverse reactions
- (2023): Simion L+, Diagnostics (Basel) 13(6), 1040 [REVIEW]
- (2022): Zhang C+, J Ovarian Res 15(1), 99 [REVIEW]
